Ge, Eva J.
Bush, Ashley I. http://orcid.org/0000-0001-8259-9069
Casini, Angela http://orcid.org/0000-0003-1599-9542
Cobine, Paul A. http://orcid.org/0000-0001-6012-0985
Cross, Justin R.
DeNicola, Gina M.
Dou, Q. Ping
Franz, Katherine J.
Gohil, Vishal M. http://orcid.org/0000-0002-9920-2563
Gupta, Sanjeev
Kaler, Stephen G.
Lutsenko, Svetlana
Mittal, Vivek http://orcid.org/0000-0002-4764-7413
Petris, Michael J.
Polishchuk, Roman http://orcid.org/0000-0002-7698-1955
Ralle, Martina http://orcid.org/0000-0001-7786-0242
Schilsky, Michael L.
Tonks, Nicholas K.
Vahdat, Linda T.
Van Aelst, Linda
Xi, Dan
Yuan, Peng http://orcid.org/0000-0002-5660-225X
Brady, Donita C. http://orcid.org/0000-0002-2786-2802
Chang, Christopher J. http://orcid.org/0000-0001-5732-9497
Article History
Accepted: 13 October 2021
First Online: 11 November 2021
Competing interests
: N.K.T. is a member of the Scientific Advisory Board of DepYmed Inc. V.M.G. is listed as an inventor on the patent application PCT/US2019/041571 submitted by Texas A&M University entitled “Compositions for the treatment of copper deficiency and methods of use”. D.C.B. holds ownership in Merlon Inc. A.I.B. holds equity in Alterity Biotechnology Ltd, Cogstate Ltd, Mesoblast Ltd and Collaborative Medicinal Development LLC and is a paid consultant for Collaborative Medicinal Development Pty Ltd. L.T.V. is a consultant for Berg Pharma, Osmol Therapeutics and Sema4, serves on the advisory board of Seattle Genetics and Immunomedics/Gilead, and receives research funding from Genentech, Arvinas, and Oncotheraphy Sciences. E.J.G, A.C., P.A.C., J.R.C, G.M.D., Q.P.D., K.J.F., S.G., S.G.K., S.L., V.M., M.J.P., R.P., M.R., M.L.S., L.V.A., D.X., P.Y. and C.J.C. declare no competing interests.